Paid Clinical Trials Memphis

Discover 567 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 567

Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

Recruiting

PHASE2

Sponsor:

Genta Incorporated

Location:

Memphis

Code:

NCT01609127

Conditions

Locally Advanced Non-resectable Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tesetaxel

Capecitabine

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Memphis, Searcy, Evansville, Saint Louisshow 121 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

Stool Sample Collection Study

Recruiting

Sponsor:

Innovis LLC

Location:

Cordova, Ocala, Anaheim

Code:

NCT06294873

Conditions

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

A screening device for the detection of colorectal and other aerodigestive tract cancers

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Recruiting

Sponsor:

Carelon Research

Location:

Memphis, Birmingham, Saint Louis, Atlantashow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

Enlighten Study: The EV-ICD Post Approval Registry

Recruiting

Sponsor:

Medtronic

Location:

Memphis, Nashville, Birmingham, Saint Louisshow 47 more

Code:

NCT06048731

Conditions

Ventricular Arrhythmia

Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Defibrillation using EV-ICD

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Memphis, Little Rock, Nashville, Jacksonshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Memphis, Nashville, Saint Louis, Atlantashow 43 more

Code:

NCT06183931

Conditions

Transthyretin Amyloid Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALXN2220

Placebo

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Recruiting

PHASE3

Sponsor:

Longboard Pharmaceuticals

Location:

Memphis, Little Rock, Atlanta, Gulf Breezeshow 22 more

Code:

NCT06660394

Conditions

Dravet Syndrome

Eligibility Criteria

Sex: All

Age: 2 - 65

Healthy Volunteers: Not accepted

Interventions

LP352

Placebo

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Memphis, Southhaven, Collierville, Bransonshow 210 more

Code:

NCT05040360

Conditions

Metastatic Malignant Neoplasm in the Liver

Pancreatic Neuroendocrine Tumor

Stage I Pancreatic Neuroendocrine Tumor AJCC v8

Stage II Pancreatic Neuroendocrine Tumor AJCC v8

Stage III Pancreatic Neuroendocrine Tumor AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Capecitabine

Temozolomide

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Recruiting

PHASE2

Sponsor:

Ipsen

Location:

Memphis, New Orleans, Lake City, Ann Arborshow 11 more

Code:

NCT06625060

Conditions

Episodic Migraine

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

IPN10200

Placebo

IPN10200 dose A

IPN10200 dose B